Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

Rhea-AI Summary

Procaps Group (NASDAQ: PROC) will participate in the BTG Pactual LatAm CEO Conference from October 11-13, 2022, in New York, NY. Key executives, including CEO Rubén Minski and CFO Patricio Vargas, will hold one-on-one meetings on October 11 and 12 to discuss the pending acquisition of Grupo Somar, 2022 performance, and strategic initiatives.

Procaps is a leading developer of pharmaceutical and nutraceutical solutions, with a presence in over 50 countries and more than 5,300 employees.

MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the InterContinental NY Barclays Hotel October 11-13, 2022.

Procaps Group Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, and Investor Relations Director Melissa Angelini will conduct in-person one-on-one meetings on October 11 and 12 during which they will discuss the pending acquisition of Grupo Somar, 2022 performance, and other strategic initiatives.

BTG Pactual LatAm CEO Conference
Date: October 11-13, 2022
Location: New York, NY
Format: In-person 1x1's and presentation
Attendees: Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, Investor Relations Director Melissa Angelini

For more information on the BTG Pactual LatAm CEO Conference or to schedule a one-on-one meeting with Procaps Group management, please contact your conference representative or you may also email your request to ir@procapsgroup.com.

About Procaps Group
Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,300 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products, prescription pharmaceutical drugs (Rx), nutritional supplements, and high-potency clinical solutions.

For more information, visit www.procapsgroup.com or Procaps’ investor relations website investor.procapsgroup.com.

Investor Contact:
Melissa Angelini
ir@procapsgroup.com
+1 754 260-6476
investor.procapsgroup.com

 

FAQ

What is the focus of Procaps Group's participation in the BTG Pactual LatAm CEO Conference?

Procaps will discuss the pending acquisition of Grupo Somar, its 2022 performance, and strategic initiatives.

When is the BTG Pactual LatAm CEO Conference taking place?

The conference will be held from October 11 to 13, 2022.

Who are the key executives representing Procaps at the conference?

CEO Rubén Minski, CFO Patricio Vargas, and Investor Relations Director Melissa Angelini will represent Procaps.

Where is the BTG Pactual LatAm CEO Conference being held?

The conference is located at the InterContinental NY Barclays Hotel in New York.

What is Procaps Group's stock symbol?

The stock symbol for Procaps Group is PROC.